These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36719516)

  • 1. Copeptin and the prognosis of patients with coronary artery disease: a meta-analysis.
    Shi Z; Qian C
    Ir J Med Sci; 2023 Oct; 192(5):2129-2141. PubMed ID: 36719516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery disease.
    von Haehling S; Papassotiriou J; Morgenthaler NG; Hartmann O; Doehner W; Stellos K; Wurster T; Schuster A; Nagel E; Gawaz M; Bigalke B
    Int J Cardiol; 2012 Dec; 162(1):27-32. PubMed ID: 22284271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copeptin predicts coronary artery disease cardiovascular and total mortality.
    Tasevska I; Enhörning S; Persson M; Nilsson PM; Melander O
    Heart; 2016 Jan; 102(2):127-32. PubMed ID: 26661323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating copeptin level and the clinical prognosis of patients with chronic liver disease.
    Tan HQ; Zhao M; Huang Z; Liu Y; Li H; Ma LH; Liu JY
    World J Gastroenterol; 2023 Aug; 29(31):4797-4808. PubMed ID: 37664154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of asymmetric dimethylarginine in patients with coronary artery disease: A meta-analysis.
    Ye J; Dai Y; Mao H; Zheng W; Zhang J
    Nitric Oxide; 2021 May; 109-110():50-56. PubMed ID: 33684543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis.
    Liu N; Hang T; Gao X; Yang W; Kong W; Lou Q; Yang J
    PLoS One; 2020; 15(9):e0238775. PubMed ID: 32886697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes.
    Velho G; Ragot S; El Boustany R; Saulnier PJ; Fraty M; Mohammedi K; Fumeron F; Potier L; Marre M; Hadjadj S; Roussel R
    Cardiovasc Diabetol; 2018 Aug; 17(1):110. PubMed ID: 30071874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The additive value of copeptin for early diagnosis and prognosis of acute coronary syndromes.
    Ahmed TAN; Johny JS; Abdel-Malek MY; Fouad DA
    Am J Emerg Med; 2021 Dec; 50():413-421. PubMed ID: 34481261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher Plasma Pentraxin-3 Level Predicts Adverse Clinical Outcomes in Patients With Coronary Artery Disease: A Meta-Analysis of Cohort Studies.
    Ding K; Shi Z; Qian C; Yang X
    Front Cardiovasc Med; 2021; 8():726289. PubMed ID: 35083296
    [No Abstract]   [Full Text] [Related]  

  • 10. High-sensitivity cardiac troponin T and copeptin assays to improve diagnostic accuracy of exercise stress test in patients with suspected coronary artery disease.
    Liebetrau C; Gaede L; Dörr O; Hoffmann J; Wolter JS; Weber M; Rolf A; Hamm CW; Nef HM; Möllmann H
    Eur J Prev Cardiol; 2015 Jun; 22(6):684-92. PubMed ID: 24699335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute glycemic variability on admission predicts the prognosis in hospitalized patients with coronary artery disease: a meta-analysis.
    Pu Z; Lai L; Yang X; Wang Y; Dong P; Wang D; Xie Y; Han Z
    Endocrine; 2020 Mar; 67(3):526-534. PubMed ID: 31828526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediabetes predicts adverse cardiovascular outcomes after percutaneous coronary intervention: a meta-analysis.
    Zhao Y; Guo M; Shi G
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31793983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of adiponectin level in patients with coronary artery disease: a systematic review and meta-analysis.
    Yang L; Li B; Zhao Y; Zhang Z
    Lipids Health Dis; 2019 Dec; 18(1):227. PubMed ID: 31870374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of copeptin after traumatic brain injury: A systematic review and meta-analysis of observational studies.
    Choi KS; Cho Y; Jang BH; Kim W; Ahn C; Lim TH; Yi HJ
    Am J Emerg Med; 2017 Oct; 35(10):1444-1450. PubMed ID: 28545954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor-23 as a biomarker of adverse outcomes in patients with coronary artery disease: a meta-analysis.
    Zheng S; Wang C; Yan H; Xu M; Du Y
    Biomarkers; 2022 Jun; 27(4):299-305. PubMed ID: 35254176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester Acute Myocardial Infarction Peptide II (LAMP II) study.
    Narayan H; Dhillon OS; Quinn PA; Struck J; Squire IB; Davies JE; Ng LL
    Clin Sci (Lond); 2011 Jul; 121(2):79-89. PubMed ID: 21309746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated copeptin is a prognostic factor for mortality even in patients with renal dysfunction.
    Engelbertz C; Brand E; Fobker M; Fischer D; Pavenstädt H; Reinecke H
    Int J Cardiol; 2016 Oct; 221():327-32. PubMed ID: 27404700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction.
    Potocki M; Reichlin T; Thalmann S; Zellweger C; Twerenbold R; Reiter M; Steuer S; Bassetti S; Drexler B; Stelzig C; Freese M; Winkler K; Haaf P; Balmelli C; Hochholzer W; Osswald S; Mueller C
    Heart; 2012 Apr; 98(7):558-65. PubMed ID: 22337952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Handgrip Strength and Mortality of Patients With Coronary Artery Disease: A Meta-Analysis.
    Xiao M; Lu Y; Li H; Zhao Z
    Clin Cardiol; 2024 Jul; 47(7):e24322. PubMed ID: 39051437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copeptin and peroxiredoxin-4 independently predict mortality in patients with nonspecific complaints presenting to the emergency department.
    Nickel CH; Ruedinger J; Misch F; Blume K; Maile S; Schulte J; Köhrle J; Hartmann O; Giersdorf S; Bingisser R
    Acad Emerg Med; 2011 Aug; 18(8):851-9. PubMed ID: 21843221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.